United Therapeutics Corporation (UTHR) Social Stream

United Therapeutics Corporation (UTHR): $267.72

1.43 (-0.53%)

POWR Rating

Component Grades








Add UTHR to Watchlist
Sign Up

Industry: Biotech




#9 of 357

in industry

Featured Post From StockTwits About UTHR


CC yesterday once again proves the company is in fantastic health & progressing as planned

🥭 MNKD Partners w/ NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI

🥭 Tyvaso DPI FDA approval OCTOBER this year

🥭 >100 new MannKind jobs being added to Danbury, CT facility

🥭 Afrezza Peds Phase 3 this year

🥭 Clofazimine Phase 1 this year

🥭 Royalties from Thyquidity Co-Promote w/ Vertice Pharma starts NOW

🥭 MannKind and Thirona Bio Join Forces to Develop Inhaled Therapy for Fibrotic Lung Diseases

🥭 BluHale Pro Launch this year

🥭 Afrezza European Union filing this year—NO additional clinical trials required

🥭 Afrezza filing in Canada

🥭 Afrezza Australia approval this year

🥭 $100M+ in annual royalties from partner $UTHR for Tyvaso DPI

🥭 >$300M in cash—enough to get us to cash flow break even

🥭 Cannabis partner Receptor Life Sciences Phase 1 incoming

🥭 Afrezza India Clinical Trial this year

🥭 Medicare coverage for Afrezza Users obtaining CGMs
mango3, published August 12, 2021

What Else are UTHR Traders Talking About?

Other tickers frequently mentioned alongside UTHR is MNKD.

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!